Parenteral Market Trends
With today’s growing pipeline of biologics, namely complex oncology products often delivered...
Posts about
Biologics
Alcami Adds Additional Formulation Development Capabilities
Formulation Development Suite to Support Small and Large Molecule Programs
Morrisville, North...
Alcami Expands Biologics Footprint with Investment in Durham
$10 Million Investment Doubles Laboratory Footprint & Enhances Large Molecule and Cell & Gene...
Bioanalytical Testing Trends in 2022
An increasing number of clinical trial registrations, more R&D investment, growing demand for...
Alcami to Provide Analytical Support Services for Novavax’ COVID-19 Vaccine Candidate
DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...
Outsourcing Trends in the Development of Biologics
The development of biologic drugs continues to increase at a rapid pace. Growing numbers of...
Fill-Finish Development Challenges & Solutions for CDMOs
Recently, contract development and manufacturing organizations (CDMOs) involved in the...
White Paper: Host Cell Impurities, Bioassays, Micro-Flow Imaging
As opposed to traditional drug production, the production of biological products (biologics)...
EDITORIAL: Combination Products and their Regulatory Pathway
Combination products are becoming increasingly important to pharmaceutical CDMOs like Alcami, said...
On-Demand Lab Open House
From standalone projects through full-service programs, our laboratories provide solutions to your...
ON-DEMAND WEBINAR: Extractables & Leachables
Requirements from regulatory agencies have become increasingly rigorous with regards to the...
Part Two: Cell-Based Bioassays
Part Two: Cell-Based Bioassays
Part One: Biologics and the Problem with Residual DNA
Part One: Biologics and the Problem with Residual DNA